Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in FL from 5225 Patients on 13 Clinical Trials.
Carla Casulo,Jesse G. Dixon,Jennifer Le-Rademacher,Eva Hoster,Howard S. Hochster,Wolfgang Hiddemann,Robert Marcus,Eva Kimby,Michael Herold,Catherine Sebban,Emmanuel Gyan,Kenneth Foon,Tina Nielsen,Umberto Vitolo,Gilles A. Salles,Qian Shi,Christopher R. Flowers Blood（2022）
AI 理解论文
溯源树
样例
